Open Fluoxetine Treatment of Mixed Anxiety Disorders in Children and Adolescents
Authors:
- Daniel S. PineDPDaniel S. Pine
- Nancy K. TancerNTNancy K. Tancer
- E. Steven DummitEDE. Steven Dummit
- Lisa M. KentgenLKLisa M. Kentgen
- Jacqueline MartinJMJacqueline Martin
- Barbara K. AscheBABarbara K. Asche
- Rachel G. KleinRKRachel G. Klein
- 1 January 1997
- journal article
- clinical trial
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 7 (1) , 17-29
Abstract
An open-label pilot study examined fluoxetine treatment in 16 outpatients (9-18 years old) with mixed anxiety disorders. Following nonresponse to psychotherapy, fluoxetine monotherapy was started at 5 mg daily and was increased weekly by 5 or 10 mg daily for 6-9 weeks until improvement occurred or to a maximum of 40 mg (children under 12) or 80 mg (adolescents). Among patients on fluoxetine, severity of illness ratings were "much improved" (mean final Clinical Global Impression scale score 2.8 +/- 0.7). Clinical improvement occurred in 10 of 10 patients with current separation anxiety disorder, 8 of 10 with social phobia, 4 of 6 with specific phobia, 3 of 5 with panic disorder, and 1 of 7 with generalized anxiety disorder. Mean time to improvement was 5 weeks. Mean doses were 24 mg (0.7 mg/kg) for children and 40 mg (0.71 mg/kg) for adolescents. Side effects were transient and included drowsiness (31% of patients), sleep problems (19%), decreased appetite (13%), nausea (13%), abdominal pain (13%), and excitement (13%). No patient developed disinhibition, akathisia, or suicidality. These preliminary findings suggest fluoxetine effectiveness in separation anxiety disorder and social phobia. Youths with only one anxiety disorder appeared to respond to lower doses of fluoxetine than patients with multiple anxiety disorders (0.49 +/- 0.14 versus 0.80 +/- 0.28 mg/kg, p < 0.05).Keywords
This publication has 4 references indexed in Scilit:
- Psychopathology from adolescence into young adulthood: an 8-year follow- up studyAmerican Journal of Psychiatry, 1995
- Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled StudyThe British Journal of Psychiatry, 1995
- The Significance of Self‐Reported Anxious Symptoms in First Grade Children: Prediction to Anxious Symptoms and Adaptive Functioning in Fifth GradeJournal of Child Psychology and Psychiatry, 1995
- Mania Associated with Fluoxetine Treatment in AdolescentsJournal of the American Academy of Child & Adolescent Psychiatry, 1992